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HE PROCESS of hematopoietic differentiation in vivo
T is sustained by interactions between hematopoietic progenitor cells, cells of the marrow microenvironment, and factors produced by these cells."* Long-term cultures (LTC) of marrow stromal cells sustain hematopoietic differentiation in vitro and may, therefore, reflect the complexity of interactions that occur in the microenvironment in vivo. For this reason, LTC are being used to investigate the mechanisms underlying the regulation of hematopoiesis in vivo.
LTC typically form confluent layers of adherent cells composed of fibroblasts, endothelial cells, adipocytes, and macrophages. It has been shown that certain of these cell types isolated from nonmarrow tissue sources have the capacity to produce, either constitutively or after appropriate stimulation, hematopoietic growth factors and/or inhibitors. Specifically, fibroblasts express macrophage (M) colonystimulating factor (CSF) messenger R N A (mRNA) constitutively, and can be stimulated with interleukin-1 (IL-1) or tumor necrosis factor-a (TNF-a) to produce granulocyte (G)M-and G-CSF.3-5 Microvascular endothelial cells produce GM-CSF constitutively,6 and vascular endothelial cells can be stimulated with IL-I or TNF-a to produce GM-CSF,7-9 G-CSF, and M-CSF.'"-" Finally, monocytes can be stimulated with adherence,'* GM-CSF,l3.l4 lipopolysaccharide,I3 and TNF-a" to produce M-CSF, G-CSF, and GM-CSF, respectively. Some cell populations may also be induced in vitro to produce factors that directly inhibit hematopoiesis such as transforming growth factor p,16,17 interferons,18 and TNF-a. I9 It is not known currently to what extent the activities produced by isolated cell populations may be involved in hematopoietic regulation in vivo or in LTC. Hypothetically, these various cell types provide a complex milieu of stimulatory and inhibitory factors localized in the microenvironment, the regulation of which is required for steady-state blood cell production, as well as establishing and maintaining a marrow graft. To pursue this hypothesis, we have investigated the growth factors produced in LTC established from 94%. CM from normal and group B stromal cell cultures contained detectable CSA, and the levels correlated with the amounts of granulocyte-CSF (G-CSF) detected by a specific bioassay. G-CSF was not detectable in medium conditioned by stromal cells from transplanted patients with poor marrow function. These results indicate that CM from stromal cells from normal subjects and transplanted patients with good marrow function contain both GM-CSF and G-CSF, while CM from stromal cells from transplanted patients with poor marrow function contain detectable levels of GM-CSF only. The reduced capacity of these stromal cells t o produce G-CSF is associated with a reduced capacity of the CM t o sustain GM colony formation and may be associated with the inability of these patients t o sustain their neutrophil counts in vivo. normal individuals, transplanted patients with good marrow function, and patients with graft failure. in 5% CO,. They were re-fed once a week by complete change of the At the time of refeeding, the culture medium was removed and the stromal cell layer washed with phosphate buffered saline (PBS). Cultures were then fed with FBS-deprived medium composed of Iscove's modified Dulbecco's medium (IMDM; GIBCO) supplemented with j!?-mercaptoethanol(7.5 x mol/L), bovine serum albumin (BSA, 5 x mol/L), iron-saturated transferrin (5 x lo-' mol/L) and lipids (see below). In one experiment, serum-free media supplemented with increasing concentrations of FBS (0.3% to 10% vol/vol) were added to replicate cultures of normal LTC. After a 3-day incubation at 37OC, the LTC supernatants were removed and assayed for the presence of burst-promoting activity (BPA) and colony-stimulating activity (CSA). Control or "mock" supernatants consisted of medium incubated in the absence of cells, but otherwise were treated the same.
MATERIALS AND METHODS

Marrow
Stromal each patient posttransplant, and indicates when the sample used for establishing LTC was obtained. It is unclear whether the apparent difference in the incidence of graft-versus-host disease (GVHD) observed between the two groups is significant. Buffy coat marrow cells were subjected to hypotonic lysis in ammonium chloride and used to establish long-term marrow cultures according to a method modified CSA and BPA assay.
Establishment of stromal cells. using cDNA sequences specific for Y-chromatin.
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tion, evaluated by AD acetate esterase staining, was 6%. Cells were then washed twice with IMDM containing 1% BSA and plated at a concentration of 3 x lo4 cells/mL. Each 1-mL dish contained the following components in IMDM: methylcellulose (0.8% wt/vol, final concentration), P-mercaptoethanol (7.5 x to-' mol/L), antibiotics (100 U penicillin, 250 ng amphotericin B, and 100 pg streptomycin), deionized BSA (2 x mol/L), BSA-adsorbed cholesterol (4 pg/mL) and soybean lecithin (12 pg/mL), iron-saturated human transferrin (9 x mol/L), insulin (1.7 x mol/L), nucleosides (10 pg/mL each), inorganic salts, sodium pyruvate mol/L), and L-glutamine (2 x mol/L), as described?',22 All chemicals were obtained from Sigma.
In each experiment, a negative control, stimulated only by Epo, and a positive control, stimulated with Epo and IL-3,23 were included. Cultures supplemented with a selected heat-inactivated lot of FBS (40%, vol/vol) and stimulated with Epo (1.5 U/mL) and/or phytohemagglutinin-stimulated leukocyte-conditioned medium (PHA-LCM; 5%, vol/vol) were also included as a standard for maximal colony growth.
Cultures were established in duplicate. Plates were incubated at 37OC in a fully humidified incubator with 5% CO, in air, and scored with an inverted microscope at 12 to 14 days for the presence of erythroid bursts and G M colonies.
Erythroid bursts (containing 2200 cells) were identified on the basis of their orange-red color. Colonies composed of more than 50 nonerythroid cells were scored as GM colonies.
Purified recombinant human hematopoietic growth factors used in these experiments included
and G-CSF26 (1,000 U/mL = 2 to 3 x lO-"mol/L) (from AMGen, Thousand Oaks, CA). IL-3 was in the form of conditioned medium from COS-1 cells transfected with a plasmid designed for expression of human IL-3" (from Genetics Institute, Cambridge, MA). The concentration of IL-3 was IO4 U/mL of CM and the specific activity was IO4 U/pg of protein (S. Clark, Genetics Institute, personal communication).
Neutralization experiments. The anti-GM-CSF neutralizing monoclonal antibody (MoAb) was affinity-purified from mouse ascites. One microliter of purified MoAb contained 1 pg of immunoglobulin and completely neutralized 100 U of GM-CSF as determined by colony-forming assay in FBS-supplemented cultures (K. Kaushansky , Division of Hematology, University of Washington, Seattle, unpublished data). The IL-3 neutralizing antiserum (a gift of Genetics Institute) was obtained from a rabbit immunized with human IL-3. Two and one half microliters of antiserum completely neutralized 10 U of IL-3 as determined by colony-forming assay in FBS-supplemented cultures (S. Clark, personal communication). For neutralizing experiments, GM-CSF, IL-3, or CM was incubated for 1 hour at room temperature (RT) with amounts of anti-GM-CSF or anti-IL-3, respectively, which were predetermined to completely neutralize the biologic activity of the growth factors in FBS-supplemented cultures. The solution was then used to stimulate colony formation in semisolid culture.
The presence of human G-CSF (greater than 100 U/mL, 3 x lo-'' mol/L) was evaluated on the basis of the capacity of the CM (20%, vol/vol) to induce colony formation from the murine cell line 32D cl 3(G)'* in semisolid cultures containing IMDM supplemented with agar (FMC BioProducts, Rockland, ME; 0.3% vol/vol), FBS (40%, vol/vol) 8-mercaptoethanol, and antibiotics. After 8 days of incubation at 37OC, the dishes were scored under an inverted microscope and colonies composed of more than 50 cells were counted.
Although the only human hematopoietic growth factor to which 32D (G) responds is G-CSF,"* the specificity of the assay was controlled by concurrent cultures using a rabbit antiserum specific Scoring criteria.
Hematopoietic growth factors.
Bioassay for human G-CSF.
for G-CSF (a gift from Dr S. Gillis, Immunex, Seattle, WA). Briefly, G-CSF or CM from normal donors was incubated for 30 minutes at RT with 0.1 pL of the rabbit antiserum. The mixture was then used to induce the growth of 32D cl 3(G) cells. The same concentration of antiserum failed to inhibit the growth of 32D cl 3(G) observed in the presence of murine IL-3 (results not shown).
RESULTS
All normal bone marrow samples, grown under LTC conditions described above, generated within 2 to 3 weeks a confluent layer of adherent cells composed of fibroblastoid cells, adipocytes, and macrophages. Cytocentrifuge preparations of trypsinized adherent cells demonstrated the predominance of two morphologically distinct cell populations: acid-phosphatase, Leu-M3-positive macrophages; and alkaline phosphatase-positive fibroblastoid cells expressing a variety of extracellular matrix proteins, suggesting both fibroblast and endothelial components as described p r e v i o~s l y .~~ Stromal cell cultures grown from hypocellular patient samples were established in either 16-mm or 35-mm dishes in place of the usual 25-cm2 flask so that confluent layers could be grown and relatively constant ratios between surface area and supernatant volume could be maintained among samples. However, this limited sample size precluded quantitative immune histochemical analysis of cellular components.
Instead, the composition of each culture was evaluated by light microscopy and the relative frequency of macrophages, adipocytes, and fibroblastoid cells rated in comparison with control cultures. Data from these observations are summarized in Table 2 .
Effect of FBS on stimulatory activities detected in LTC-CM. Experiments were done to determine whether FBS in the LTC-CM affected the detectable level of BPA and CSA (Fig 2) . FBS-deprived medium, by itself, did not induce colony growth in FBS-deprived colony assays, while medium containing FBS only supported growth of erythroid bursts. Stimulatory effect was correlated with the amount of FBS present in the media. Therefore, to increase the sensitivity of our assays, the LTC-CM was generated under serumdeprived conditions. Quantitation of BPA and CSA in supernatants from stromal cell cultures. BPA and CSA in the supernatants from stromal cell cultures were quantitated according to arbitrary units. Since PHA-LCM and recombinant IL-3 or GM-CSF alone do not induce maximal numbers of erythroid bursts or GM-colonies under FBS-deprived conditions," the number of erythroid bursts and GM-colonies detected in FBS-supplemented cultures in the presence of PHA-LCM was set at 100%.
Stromal cell cultures.
Accordingly, a supernatant that induced the same number of erythroid bursts or G M colonies observed in FBSsupplemented cultures stimulated with Epo and/or PHA-LCM would contain 100 U of BPA or CSA, respectively. An example of how these arbitrary units were calculated is reported in Table 3 .
To define maximal concentration of the C M that could be tested without inhibitory effects on colony growth, the effect of increasing concentrations (1% to 20%, vol/vol) of C M from three different stromal cell cultures on the growth of G M colonies and erythroid bursts was measured (Fig 3) . Because maximal colony-stimulating effect for one C M was observed at a concentration of 20%, vol/vol, and this concentration did not inhibit in the other two instances, this concentration was chosen to test all CM.
Variability observed between the levels of BPA and CSA detected for the same supernatant tested on different marrow cells, as well as the degree of variability in BPA and CSA content detected in supernatants derived from the same marrow grown in separate flasks, was less than 15% (results not shown). No significant association was observed between LTC age and the amount of activities detected (Fig 4) .
BPA and CSA detected in supernatants from stromal cells. Figure 5 shows the levels of BPA and CSA detected in supernatants from stromal cells derived from normals and group A or B transplanted subjects. Normals had a mean (+SEM) of 34(+5) U BPA and 27(+7) U CSA. C M from group A patients (poor marrow function) and group B patients (good marrow function) had mean values of 33(+5) and 56(+19) U BPA and 6(+3) and 61(+7) U CSA, respectively. Stromal cells of the two experimental groups produced significantly different (P 5 .01) levels of CSA, but not BPA.
To identify growth factors responsible for the BPA and CSA detected in the CM, neutralization experiments were performed. Each C M was preincubated for at least 1 hour with an anti-GM-CSF monoclonal or rabbit anti-IL-3 serum before being used as a stimulus for erythroid burst or G M colony growth. Results obtained are summarized in Table 4 . Preincubation with the anti-GM-CSF monoclonal inhibited CM-stimulated burst formation by 90%. This was true for C M obtained from normal and patient LTC. Anti-IL-3 serum had no effect on the growth of CM-stimulated erythroid bursts. Preincubation with the anti-GM-CSF monoclonal inhibited CMstimulated GM colony growth by 50%.
The presence of G-CSF in the stromal cell C M was evaluated on the basis of the capacity of the C M to sustain colony formation by a G-CSF-responsive version of the murine mast cell/basophil cell line 32D cl 3(G).28 To prove that G-CSF was responsible for the colony growth, C M were used, either unmodified or after preincubation, with a rabbit neutralizing anti-G-CSF
Neutralization experiments.
Bioassay for human G-CSF. U/mL) was added to detect erythroid bursts. Mock CM is represented by culture medium not exposed to stromal cells. tunits of BPA and CSA calculated as percent of the number of colonies observed in FBS-supplemented cultures stimulated with PHA-LCM. Numbers of bursts obtained with no stimulus or mock CM were considered background levels and subtracted from experimental numbers before calculation of BPA and CSA units. antiserum (Table 5 ). In the supernatant from normal stromal cells, the level of G-CSF detected with this assay correlated directly ( I = .82, P = .01) with the level of CSA detected in cultures of human marrow (Fig 6 ) .
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Supernatants from group A (poor marrow function) stromal cells did not have detectable G-CSF by this assay (Table   "1 5). However, C M did not inhibit the growth of the 32D cl 3(G) observed in the presence of a suboptimal concentration of G-CSF ( Table 5 ), suggesting that it was the absence of G-CSF rather than the presence of an inhibitor that was responsible for the observations.
DISCUSSION
To define the role played by stromal cells in the control of hematopoiesis, supernatants from cultures of marrowderived stromal cells have been extensively investigated for the presence of activities able to stimulate formation of We provide evidence that supernatants obtained under serum-deprived conditions from normal unstimulated stromal cells contain detectable levels of BPA and CSA. The level of activities detected in the cultures from different donors was heterogeneous; however, unlike the studies of Fibbe et al,34 this heterogeneity was not inversely correlated with the age of the cultures.
To identify the growth factors responsible for the BPA, C M were preincubated with an anti-GM-CSF MoAb or an anti-IL-3 serum. BPA in these C M was neutralized only by the anti-GM-CSF antibody. These results are in agreement with the observation that GM-CSF mRNA, but not IL-3 mRNA, is detectable in human3' and murine36 stromal cell cultures. Since GM-CSF induces growth or erythroid bursts in serum-deprived cultures a t concentrations higher than IO-" m0l/L,2~3~' and we have been unable to detect the presence of GM-CSF in these supernatants by radioimmunoassay (limit of detection mol/L), the concentration of GM-CSF in these C M is estimated to be between lo-'' and Previous studies showed that GM-CSF alone has very little, if any, CSA in serum-deprived culture^.*^.^^ In the present study, the anti-GM-CSF MoAb only partially neutralized the CSA detected in these supernatants. In keeping with these observations, the CSA in the C M was correlated to the level of G-CSF detectable by bioassay (limit of detection 50 U/mL). Once again, no G-CSF was detectable by radioimmunoassay; however, the limit of detection of this assay is 2,000 U/mL.
All C M from stromal cells derived from transplanted patients had BPA a t levels not statistically different from those observed in C M from normal stromal cells. In contrast, only medium conditioned by stromal cells from patients with good marrow function, and not those with poor marrow moI/L. function, could induce high levels of G M colony growth in FBS-deprived cultures of nonadherent marrow cells. In keeping with this, G-CSF was only detected by bioassay in the C M from patients with good marrow function. Hypothetically, the absence of CSA in the C M from patients with poor marrow function could be due not only to the absence of G-CSF but also to the presence of a growth inhibitor. Although inhibitory experiments have not been formally done, the observation that C M from these patients stimulated erythroid burst growth as efficiently as the control C M argues against the presence of an inhibitor.
Identification of specific stromal cells that produce growth factors, as well as the signals that regulate this production in situ, comprise active areas of research. Presently, in normal functioning stromal cultures, we have not directly associated a specific cell type with the production of a specific factor. In the studies presented here, we have observed that there were no morphologic differences in the stromal cultures estab- pocytes and fibroblasts. Despite these differences, the abnor- In conclusion, we provide evidence that by using FBSdeprived cultures it is possible to detect BPA and CSA in the CM of unstimulated human stromal cell cultures. By using neutralizing antibodies or specific bioassays involving growthfactor-dependent cell lines, we identified the presence of GM-CSFand G-CSF a t concentrations not otherwise detectable. As an example of the possible applications of this methodology, we provide evidence that media conditioned by stromal cells from transplanted patients with poor marrow function have a reduced ability to sustain GM colony growth and have undetectable levels of G-CSF. 
